Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketofol vs Methohexital Anesthesia for ECT in Depression
NCT05655754Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine, propofol injection (veterinary) in major depressive disorder (MDD), sponsored by Medical University of Vienna. Started Nov 2022; status: completed.
02
Drugs
esketaminepropofol injection (veterinary)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05655754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05655754.